Stephen S. Gottlieb, MD | oneAMYLOIDOSISvoice
×
Or register here
Global Search

Trusted Resources: People & Places

Healthcare providers, researchers, and advocates

Back to People / Healthcare Professionals
Stephen S. Gottlieb, MD

Stephen S. Gottlieb, MD

Healthcare Professional
Director
Clinical Research Program in Cardiology
University of Maryland Medical Center
22 South Greene Street
Baltimore, Maryland, United States

Dr Gottlieb got trained at Brown University, University of Chicago and Mt Sinai in New York. He has been at the University of Maryland since 1988, and is currently Professor of Medicine, and Director of the Clinical Research Program in Cardiology. He has completed his residency at University of Chicago Medical Center and fellowship at Mount Sinai School of Medicine in cardiology.

Dr. Gottlieb’s investigations center on the physiology and therapy of congestive heart failure. This has included a particular interest in neurohormonal activation and renal function in CHF patients. He is particularly interested in the interaction of heart failure and renal dysfunction, having studied the impact of adenosine antagonists and other medications and interventions on renal function and the physiology of renal function in heart failure patients. 

Dr. Gottlieb’s special interests include cardiac amyloidosis, cardio renal syndrome, congestive heart failure, as well as research trials in heart failure.


Representative Publications:

Importance and Management of Chronic Sleep Apnoea in Cardiology

Effects of Nesiritide and Predictors of Urine Output in Acute Decompensated Heart Failure: Results From ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide and Decompensated Heart Failure)

The Effect of a Randomized Trial of Home Telemonitoring on Medical Costs, 30-Day Readmissions, Mortality, and Health-Related Quality of Life in a Cohort of Community-Dwelling Heart Failure Patients

Trastuzumab-Induced Cardiomyopathy: Incidence and Associated Risk Factors in an Inner-City Population

High Concordance Between Mental Stress-Induced and Adenosine-Induced Myocardial Ischemia Assessed Using SPECT in Heart Failure Patients: Hemodynamic and Biomarker Correlates.

view profile

Related Content

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close

Community Key Collaborator

Support for this landing page is provided by an independent education grant from

Translation of this platform made possible through an independent education grant from

© 2024 rareLife solutions Inc.

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close